XTLB
Xtl Biopharmaceuticals
$2.88
−$0.06 (−2.04%)Jul 27, 2026
Key metrics
The numbers that frame XTLB today
- Market cap
- $8.18M
- P/E (TTM)
- -1.2
- EV / FCF
- -8.2
- ROIC
- 1,450.4%
- Div yield
- 0%
- 52wk Low
- $2.02
- 52wk High
- $13.07
Growth
Revenue and earnings trend for XTLB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XTLB
Is Xtl Biopharmaceuticals a good buy?
No. Xtl Biopharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. We think Xtl Biopharmaceuticals is selling at a very high price.
What is the market capitalization of XTLB?
Xtl Biopharmaceuticals's market capitalization is $8.18M.
What is the P/E ratio for XTLB stock?
Xtl Biopharmaceuticals's current P/E ratio is -1.2.
What is the 52-week high for XTLB stock?
The 52-week high for Xtl Biopharmaceuticals is $13.07. The current close of $2.88 is 78% below that high.
What is the 52-week low for XTLB stock?
The 52-week low for Xtl Biopharmaceuticals is $2.02. The current close of $2.88 is 42.6% above that low.
Does XTLB stock pay dividends?
Xtl Biopharmaceuticals does not currently show a dividend per share in the company data.